Streetbeat News

Revenues

ETH-USD

GOOGL

The article discusses the potential of blockchain technology to disrupt the digital advertising industry, which is projected to reach $667 billion globally in 2024. It highlights Alkimi Exchange, a decentralized ad exchange built on Ethereum, as a solution to improve transparency and efficiency in ad spending. The article also mentions Google's dominance in the advertising space and the ongoing scrutiny it faces from the U.S. Federal Government.

Portfolio Pulse from Justin Roberti

October 22, 2024 | 6:40 pm

TVGN

Tevogen Bio is set to announce timelines for revenue forecast updates and operational readiness, expecting $1 billion in revenue during the launch years for oncology and specialty care. The 5-year revenue estimate is between $28 billion and $36 billion. Updates on Tevogen AI and manufacturing progress will also be provided.

Portfolio Pulse from Benzinga Newsdesk

October 22, 2024 | 6:35 pm

F

GM

TSLA

General Motors (GM) exceeded Wall Street's Q3 expectations, driven by strong U.S. pickup demand, and raised its full-year guidance. GM's revenue increased by 10.5% YoY to $48.76 billion, with adjusted EPS up 30% YoY. GM's EV deliveries surged 60% YoY, surpassing Ford's EV growth. However, GM faces challenges in China and the EV market.

Portfolio Pulse from Upwallstreet

October 22, 2024 | 6:34 pm

VZ

Goldman Sachs analyst James Schneider maintained a Buy rating on Verizon with a price target of $52. Verizon's Q3 results were in line with expectations, with revenue slightly below consensus. The company reaffirmed its 2024 guidance, and investor focus is expected to shift to its broadband strategy.

Portfolio Pulse from Anusuya Lahiri

October 22, 2024 | 6:08 pm

TTWO

Analysts have mixed views on Take-Two Interactive (NASDAQ:TTWO) with a majority being bullish. Recent evaluations show a slight increase in the average 12-month price target to $191.73. Despite positive revenue growth, the company faces challenges with profitability and asset returns.

Portfolio Pulse from Benzinga Insights

October 22, 2024 | 6:05 pm

SHAK

Shake Shack (NYSE:SHAK) has received mixed analyst ratings over the past three months, with a recent average price target of $114.07, reflecting a 3.51% increase. Analysts have varied in their ratings, with some raising and others lowering their price targets. Shake Shack has shown strong revenue growth but faces challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

October 22, 2024 | 6:05 pm

UNH

The article discusses recent analyst ratings for UnitedHealth Group (NYSE:UNH), highlighting a mix of bullish and somewhat bullish perspectives. Analysts have set a 12-month average price target of $616.94, with a high of $675.00 and a low of $591.00. Recent actions include both raises and lowers in ratings and price targets by various analysts. UnitedHealth Group shows strong financial performance with a solid revenue growth rate, high net margin, and impressive ROE and ROA, but faces challenges with a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 22, 2024 | 6:05 pm

GNRC

Generac Holdings (NYSE:GNRC) has received a range of analyst ratings over the past three months, with a notable increase in the average 12-month price target to $175.88. Analysts have shown a mix of bullish and neutral sentiments, with several raising their price targets. Despite a slight decline in revenue growth, Generac's financial metrics like net margin, ROE, and ROA remain strong, indicating effective cost management and financial health.

Portfolio Pulse from Benzinga Insights

October 22, 2024 | 6:05 pm

KVUE

Analysts have provided diverse evaluations of Kenvue (NYSE:KVUE) over the past three months, with a mix of bullish and somewhat bullish ratings. The average 12-month price target has increased to $24.1. Kenvue, a leading consumer health company, faces challenges with a slight revenue decline but maintains strong financial metrics like net margin and ROE.

Portfolio Pulse from Benzinga Insights

October 22, 2024 | 6:04 pm

CBUS

Analysts have provided mixed ratings for Cibus (NASDAQ:CBUS) over the past three months, with a majority maintaining a bullish outlook. The average 12-month price target is $21.9, slightly down from $22.00. Cibus has shown significant revenue growth but faces challenges with profitability.

Portfolio Pulse from Benzinga Insights

October 22, 2024 | 6:02 pm